Submitted by elizabethwu1 on Fri, 11/22/2013 - 1:55pm NCT00568776 ELND005 United States Saturday, December 1, 2007 – Saturday, May 1, 2010 353 Phase 2 Alzheimer's Disease Friday, November 22, 2013 Elan Corporation Transition Therapeutics, Inc. Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by elizabethwu1 on
Submitted by elizabethwu1 on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.